Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1200 of 2529 entries
View as:

Expanded Treatment Prot of Panobinostat in Combo w/ Bortez and Dex in Pts w/ Relapsed and/or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02204553 Org: User:
Start: - End: - Due: -

Ofatumumab Bendamustine Combination Compared With Bendamustine Monotherapy in Indolent B-cell NHL Unresponsive to Rituxtherapy

Phase: N/A Priority: Normal
NCT ID: NCT01077518 Org: User:
Start: 08/26/10 End: 12/26/18 Due: 12/26/19

Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic Acid

Phase: N/A Priority: Normal
NCT ID: NCT00097812 Org: User:
Start: 05/31/04 End: 12/31/05 Due: 12/31/06

Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT00110617 Org: User:
Start: 05/31/05 End: 04/30/08 Due: 04/30/09

A Study to Investigate the Effect of Food on Oral LBH589 Absorption in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00570284 Org: User:
Start: 11/30/07 End: 02/28/11 Due: 02/28/12

Gastrointestinal and Health-related Quality of Life Outcomes in Patients With Autoimmune Diseases Treated With Mycophenolate

Phase: N/A Priority: Normal
NCT ID: NCT00351377 Org: User:
Start: 06/30/06 End: 06/30/09 Due: 06/30/10

Study to Assess the Real World Effectiveness of Inclisiran in Chinese Adult Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT05118230 Org: User:
Start: 12/09/21 End: 07/20/24 Due: 07/20/25

Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)

Phase: N/A Priority: Normal
NCT ID: NCT03945318 Org: User:
Start: 04/08/19 End: 04/13/26 Due: 04/13/27

A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01703312 Org: User:
Start: 11/30/12 End: 10/31/13 Due: 10/31/14

SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance

Phase: N/A Priority: Normal
NCT ID: NCT01266148 Org: User:
Start: 11/30/09 End: 12/31/12 Due: 12/31/13

Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment

Phase: N/A Priority: Normal
NCT ID: NCT00881205 Org: User:
Start: 04/30/09 End: 01/31/11 Due: 01/31/12

Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01357239 Org: User:
Start: 05/31/11 End: 01/31/14 Due: 01/31/15

A Single-dose, Open-label, Parallel-group Study to Assess the Pharmacokinetics of BAF312 in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT01904214 Org: User:
Start: 07/31/13 End: 11/30/14 Due: 11/30/15

Combination Of Lapatinib With Carboplatin, Paclitaxel, and With or Without Trastuzumab In Metastatic Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00367471 Org: User:
Start: 12/07/06 End: 09/12/19 Due: 09/12/20

Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT00414440 Org: User:
Start: 12/31/06 End: 10/31/13 Due: 10/31/14

Pharmacokinetics Study of Asciminib in Subjects With Impaired Renal Function Compared to Matched Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03605277 Org: User:
Start: 11/16/18 End: 04/14/19 Due: 04/14/20

Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML

Phase: N/A Priority: Normal
NCT ID: NCT01883362 Org: User:
Start: 02/06/14 End: 04/30/18 Due: 04/30/19

Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension)

Phase: N/A Priority: Normal
NCT ID: NCT00442741 Org: User:
Start: 07/31/07 End: - Due: -

Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT01333501 Org: User:
Start: 05/31/11 End: 09/30/15 Due: 09/30/16

Pharmacokinetics of Dabrafenib in Subjects With Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02852239 Org: User:
Start: 12/19/16 End: 09/27/19 Due: 09/27/20

A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistamines

Phase: N/A Priority: Normal
NCT ID: NCT05032157 Org: User:
Start: 12/01/21 End: 01/05/24 Due: 01/05/25

Study of Safety and Efficacy of CFZ533 in Type 1 Diabetes Pediatric and Young Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04129528 Org: User:
Start: 11/08/19 End: 06/04/24 Due: 06/04/25

AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme

Phase: N/A Priority: Normal
NCT ID: NCT00107237 Org: User:
Start: 10/31/03 End: 06/30/06 Due: 06/30/07

Dose-escalating Study of LBH589 in Adult Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00739414 Org: User:
Start: 07/31/08 End: - Due: -

Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH)

Phase: N/A Priority: Normal
NCT ID: NCT04147195 Org: User:
Start: 06/04/20 End: 01/06/22 Due: 01/06/23